Buchert R, Meyer PT, Albert NL, Barthel H, Boecker H, Bouter C, Brendel M, Brumberg J, Coenen HH, Drzezga A, Gründer G, Grünwald F, Hesse S, Kuwert T, la Fougère C, Lange C, Lohmann P, Menzel C, Miederer I, Neumaier B, Rominger A, Schmitz CN, Schreckenberger M, Yakushev I, Kranert WT (2026)
Publication Type: Journal article
Publication year: 2026
DOI: 10.1055/a-2821-9573
This procedure guideline for brain perfusion SPECT is intended to support the planning, execution, quality control, evaluation and reporting of brain perfusion SPECT studies using the 99 mTc-labelled radiopharmaceuticals [99 mTc]Tc-HMPAO and [99 mTc]Tc-ECD. It is an update and expansion built on the 2019 version of the procedure guideline. It was developed through an informal process as a consensus of the Neuroimaging Working Group of the German Society of Nuclear Medicine. It is intended for use by physicians and physical-technical staff (technologists, physicists) working in nuclear medicine.
APA:
Buchert, R., Meyer, P.T., Albert, N.L., Barthel, H., Boecker, H., Bouter, C.,... Kranert, W.T. (2026). German Society of Nuclear Medicine procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals (09/2025) S1-Handlungsempfehlung der Deutschen Gesellschaft für Nuklearmedizin zur Durchführung von Hirnperfusions-SPECT-Untersuchungen mit 99mTc-markierten Radiopharmaka (Stand 09/2025). Nuklearmedizin-Nuclear Medicine. https://doi.org/10.1055/a-2821-9573
MLA:
Buchert, Ralph, et al. "German Society of Nuclear Medicine procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals (09/2025) S1-Handlungsempfehlung der Deutschen Gesellschaft für Nuklearmedizin zur Durchführung von Hirnperfusions-SPECT-Untersuchungen mit 99mTc-markierten Radiopharmaka (Stand 09/2025)." Nuklearmedizin-Nuclear Medicine (2026).
BibTeX: Download